Outer membrane vesicle vaccines
Outer Membrane Vesicles (OMV) have received increased attention in recent years as a vaccine platform against bacterial pathogens. OMV from Neisseria meningitidis serogroup B have been extensively explored. Following the success of the MeNZB OMV vaccine in controlling an outbreak of N. meningitidis...
Κύριοι συγγραφείς: | Micoli, F, MacLennan, CA |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Elsevier
2020
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1
ανά: Marini, A, κ.ά.
Έκδοση: (2017) -
Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella
ανά: Micoli, F, κ.ά.
Έκδοση: (2018) -
Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.
ανά: Arianna Marini, κ.ά.
Έκδοση: (2017-01-01) -
Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines
ανά: Francesca Micoli, κ.ά.
Έκδοση: (2023-05-01) -
Outer Membrane Vesicles: An Emerging Vaccine Platform
ανά: Dharmendra Kashyap, κ.ά.
Έκδοση: (2022-09-01)